Anders A. Sima, MD, PhD
Affiliations: | Pathology | Wayne State University, Detroit, MI, United States |
Google:
"Anders Sima"Bio:
WAYNE STATE UNIVERSITY
PATHOLOGY DEPARTMENT
540 E CANFIELD ST
DETROIT, MI 482011928
United States
Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sima AA, Zhang W. (2014) Mechanisms of diabetic neuropathy: axon dysfunction. Handbook of Clinical Neurology. 126: 429-42 |
| Biessels GJ, Bril V, Calcutt NA, et al. (2014) Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). Journal of the Peripheral Nervous System : Jpns. 19: 77-87 |
| Hur J, Sullivan KA, Pande M, et al. (2011) The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain : a Journal of Neurology. 134: 3222-35 |
| Sima AA. (2010) Encephalopathies: the emerging diabetic complications. Acta Diabetologica. 47: 279-93 |
| Sima AA, Zhang W, Kreipke CW, et al. (2009) Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide. The Review of Diabetic Studies : Rds. 6: 37-42 |
| Wiggin TD, Sullivan KA, Pop-Busui R, et al. (2009) Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 58: 1634-40 |
| Hoffman WH, Artlett CM, Zhang W, et al. (2008) Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis. Brain Research. 1238: 154-62 |
| Sima AA. (2008) The heterogeneity of diabetic neuropathy. Frontiers in Bioscience : a Journal and Virtual Library. 13: 4809-16 |
| Sima AA, Zhang W, Li ZG, et al. (2008) The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat. Experimental Diabetes Research. 2008: 230458 |
| Slusher BS, Rojas C, Sima A, et al. (2008) NAALADase (GCP II) inhibition as a novel therapeutic target for neuropathic pain, diabetic neuropathy, and ALS Journal of Neurochemistry. 81: 69-70 |